It is a pharma private limited company based in Punjab, Punjab, India, established in 2003.
2003 | Punjab, Punjab, India | ActiveLimbos Pharmaceuticals Private Limited, a active private limited company, was established on 28 November 2003 in Punjab, Punjab, India. Engaging in pharmaceutical retailers & distributors within the manufacturing sector, it holds CIN: U24232PB2003PTC026568. Registered under ROC Roc Chandigarh. it is unlisted. It has an authorized capital of ₹0.40 M and a paid-up capital of ₹0.40 M.
It upholds a compliant status. Its leadership includes Gagandeep Kataria (Director), Surinder Singh Kataria (Director), Kulwinder Kataria (Director). Past directors included Kulwinder Kataria. It holds no open charges and ₹1.80 M settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 10-Gkitchlu Nagar Ludhiana, Punjab, Punjab.
U24232PB2003PTC026568
026568
28 November 2003
₹0.40 M
₹0.40 M
Roc Chandigarh
Unlisted
Active
Explore comprehensive insights into Limbos Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Gagandeep Kataria | Director | 28 Nov 2003 | Current |
| Surinder Singh Kataria | Director | 28 Nov 2003 | Current |
| Kulwinder Kataria | Director | 29 Jun 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Jun 2010 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Limbos Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 20.52% increase. The company also saw a substantial improvement in profitability, with a 69.06% increase in profit. The company's net worth observed a substantial decline by a decrease of 11.4%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2019, Limbos Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹1,798,908.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Mar 2018 | Yes Bank Limited | ₹0.60 M | Satisfied |
| 23 Feb 2012 | State Bank Of India | ₹0.80 M | Satisfied |
| 11 Dec 2008 | Punjab National Bank | ₹0.40 M | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Limbos Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Limbos Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Limbos Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Limbos Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Limbos Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chandigarh. was completed.
Progress on A charge registered on 21 Mar 2018 via Charge ID 100170140 with Yes Bank Limited was fully satisfied on 30 Jun 2023. was documented.
Progress on A charge registered on 23 Feb 2012 via Charge ID 10347786 with State Bank Of India was fully satisfied on 21 Dec 2021. was documented.
Progress on Kulwinder Kataria was appointed as a Director was appointed as a Director on 29 Jun 2020 & has been associated with this company since 5 years 5 months . was documented.
A charge with Yes Bank Limited amounted to Rs. 0.60 M with Charge ID 100170140 was registered on 21 Mar 2018. was recorded as a recent event.
The CIN of Limbos Pharmaceuticals Private Limited is U24232PB2003PTC026568.
Limbos Pharmaceuticals Private Limited is headquartered at 10-Gkitchlu Nagar Ludhiana, Punjab, Punjab.
Limbos Pharmaceuticals Private Limited was incorporated on 28 November 2003.
The current directors of Limbos Pharmaceuticals Private Limited are
The primary industry of Limbos Pharmaceuticals Private Limited is Manufacturing.
Limbos Pharmaceuticals Private Limited is unlisted.
The authorized capital of Limbos Pharmaceuticals Private Limited is ₹0.40 M, and the paid-up capital is ₹0.40 M.
The compliance status of Limbos Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX